Controlling pain after arthroscopic surgeries - how does regional anaesthesia fair against simple injections around shoulder

Analysing the efficacy of periarticular shoulder injections in pain control after arthroscopic rotator cuff repair - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072691

Enrollment

150

Registered

2024-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M751- Rotator cuff tear or rupture, notspecified as traumatic

Interventions

Intervention1: Periarticular shoulder injection: Periarticular shoulder injection involves the injection of a combination of drugs around the shoulder joint. Sites of Injection: 1. Portal sites 2. S

Drug used: Bupivacaine Dose: 0.5% Bupivacaine - 30 Ml Frequency: Only once

Eligibility

Inclusion criteria

Inclusion criteria: All patients with rotator cuff tear planned for arthroscopic cuff repair

Exclusion criteria

Exclusion criteria: Renal or liver compromise Asthmatic patients Glaucoma patients

Design outcomes

Primary

Measure	Time frame
VAS pain score Timepoint: 3,12,24 and 48 hours post-surgery	—

Secondary

Measure	Time frame
Analgesic requirement post-surgeryTimepoint: 48 hours post surgery	—

Countries

India

Contacts

Public ContactGirinivasan Chellamuthu

MIOT International Hospital

giri.c.nivasan@gmail.com8667087047

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026